In this regard, as part of the chronic inflammatory process characteristic of this disease, increased IL-17 levels have been previously linked to obesity (66), and hepatic IL-17 signalling pathway has been identified as a contributor in the amelioration of MAFLD following Roux-en-Y gastric bypass surgery (67). The gene discussed is IL17A; the disease is obesity disorder.